PharmaZell and Novasep come together to form a formidable API and CDMO platform
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
Anti-malaria API facility will be operational in 15-18 months
Ibuprofen and Famotidine Tablets is an AB-rated generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis Tablets, 800 mg/26.6 mg
The govt has rolled out three schemes for promoting the manufacture of API
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
The US FDA has closed the observations pertaining to this audit with an Establishment Inspection Report on the 20th of July 2021
This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent
Subscribe To Our Newsletter & Stay Updated